We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04744831
Brief Title: Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer (DESTINY-CRC02)

First Submitted : January 19, 2021
First Submitted that Met QC Criteria : February 4, 2021
First Posted : February 9, 2021

Last Update Submitted that Met QC Criteria : June 10, 2022
Last Update Posted : June 13, 2022